2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
- PMID: 22389040
- DOI: 10.1002/art.34356
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Abstract
The objective of this study was to develop European League Against Rheumatism/American College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). Candidate criteria were evaluated in a 6-month prospective cohort study of 125 patients with new-onset PMR and 169 non-PMR comparison subjects with conditions mimicking PMR. A scoring algorithm was developed based on morning stiffness >45 minutes (2 points), hip pain/limited range of motion (1 point), absence of rheumatoid factor and/or anti-citrullinated protein antibody (2 points), and absence of peripheral joint pain (1 point). A score ≥4 had 68% sensitivity and 78% specificity for discriminating all comparison subjects from PMR. The specificity was higher (88%) for discriminating shoulder conditions from PMR and lower (65%) for discriminating RA from PMR. Adding ultrasound, a score ≥5 had increased sensitivity to 66% and specificity to 81%. According to these provisional classification criteria, patients ≥50 years old presenting with bilateral shoulder pain, not better explained by an alternative pathology, can be classified as having PMR in the presence of morning stiffness >45 minutes, elevated C-reactive protein and/or erythrocyte sedimentation rate, and new hip pain. These criteria are not meant for diagnostic purposes.
Copyright © 2012 by the American College of Rheumatology.
Comment in
-
Provisional classification [corrected] criteria for polymyalgia rheumatica: moving beyond clinical intuition?Arthritis Rheum. 2012 Apr;64(4):955-7. doi: 10.1002/art.34389. Arthritis Rheum. 2012. PMID: 22389041 No abstract available.
Similar articles
-
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329. Ann Rheum Dis. 2012. PMID: 22388996 Free PMC article.
-
Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study.J Rheumatol. 2016 May;43(5):893-900. doi: 10.3899/jrheum.151103. Epub 2016 Feb 1. J Rheumatol. 2016. PMID: 26834222
-
The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.J Rheumatol. 2000 Sep;27(9):2179-84. J Rheumatol. 2000. PMID: 10990231
-
Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica.Reumatismo. 2018 Mar 27;70(1):18-22. doi: 10.4081/reumatismo.2018.1107. Reumatismo. 2018. PMID: 29589399 Review.
-
Recent advances in polymyalgia rheumatica.Intern Med J. 2015 Nov;45(11):1102-8. doi: 10.1111/imj.12823. Intern Med J. 2015. PMID: 26036315 Review.
Cited by
-
The Emerging Era of Interventional Imaging in Rheumatology: An Overview During the Coronavirus Disease-2019 (COVID-19) Pandemic.Open Access Rheumatol. 2022 Apr 11;14:43-56. doi: 10.2147/OARRR.S355140. eCollection 2022. Open Access Rheumatol. 2022. PMID: 35449707 Free PMC article. Review.
-
Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination.Intern Med. 2022 Mar 15;61(6):903-906. doi: 10.2169/internalmedicine.8829-21. Epub 2021 Dec 28. Intern Med. 2022. PMID: 34980802 Free PMC article.
-
Naïve Inflammatory Proteome Profiles of Glucocorticoid Responsive Polymyalgia Rheumatica and Rheumatic Arthritis Patients-Links to Triggers and Proteomic Manifestations.J Pers Med. 2024 Apr 25;14(5):449. doi: 10.3390/jpm14050449. J Pers Med. 2024. PMID: 38793033 Free PMC article.
-
Comorbidities in polymyalgia rheumatica: a systematic review.Arthritis Res Ther. 2018 Nov 20;20(1):258. doi: 10.1186/s13075-018-1757-y. Arthritis Res Ther. 2018. PMID: 30458857 Free PMC article.
-
Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection.Front Pharmacol. 2021 May 20;12:616719. doi: 10.3389/fphar.2021.616719. eCollection 2021. Front Pharmacol. 2021. PMID: 34093176 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials